Grandfield & Dodd, LLC

SEC CIK: 0001308016
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by Grandfield & Dodd, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 14,820
Value: $1.34M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of ABT by Grandfield & Dodd, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	14,820	$1.34M	0.1%	+38+0.3%	Added	Holders
Q1 2026	14,782	$1.52M	0.1%	+700+5.0%	Added	Holders
Q4 2025	14,082	$1.76M	0.1%	−567−3.9%	Reduced	Holders
Q3 2025	14,649	$1.96M	0.1%	00.0%	Unchanged	Holders
Q2 2025	14,649	$1.99M	0.1%	+486+3.4%	Added	Holders
Q1 2025	14,163	$1.88M	0.1%	−24−0.2%	Reduced	Holders
Q4 2024	14,187	$1.60M	0.1%	−88−0.6%	Reduced	Holders
Q3 2024	14,275	$1.63M	0.1%	−290−2.0%	Reduced	Holders
Q2 2024	14,565	$1.51M	0.1%	−50−0.3%	Reduced	Holders
Q1 2024	14,615	$1.66M	0.1%	00.0%	Unchanged	Holders
Q4 2023	14,615	$1.61M	0.1%	−38−0.3%	Reduced	Holders
Q3 2023	14,653	$1.42M	0.1%	−142−1.0%	Reduced	Holders
Q2 2023	14,795	$1.61M	0.1%	−312−2.1%	Reduced	Holders
Q1 2023	15,107	$1.53M	0.1%	+857+6.0%	Added	Holders
Q4 2022	14,250	$1.56M	0.1%	−28−0.2%	Reduced	Holders
Q3 2022	14,278	$1.38M	0.1%	00.0%	Unchanged	Holders
Q2 2022	14,278	$1.55M	0.1%	−1,033−6.7%	Reduced	Holders
Q1 2022	15,311	$1.81M	0.1%	−300−1.9%	Reduced	Holders
Q4 2021	15,611	$2.20M	0.1%	−173−1.1%	Reduced	Holders
Q3 2021	15,784	$1.86M	0.1%	00.0%	Unchanged	Holders
Q2 2021	15,784	$1.83M	0.1%	−696−4.2%	Reduced	Holders
Q1 2021	16,480	$1.98M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.